Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001071190 | SCV001236478 | uncertain significance | Joubert syndrome 14 | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 269 of the TMEM237 protein (p.Ala269Val). This variant is present in population databases (rs768672107, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TMEM237-related conditions. ClinVar contains an entry for this variant (Variation ID: 864086). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TMEM237 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002555904 | SCV003741639 | uncertain significance | Inborn genetic diseases | 2021-12-17 | criteria provided, single submitter | clinical testing | The c.806C>T (p.A269V) alteration is located in exon 9 (coding exon 9) of the TMEM237 gene. This alteration results from a C to T substitution at nucleotide position 806, causing the alanine (A) at amino acid position 269 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV001071190 | SCV004809390 | uncertain significance | Joubert syndrome 14 | 2024-04-04 | criteria provided, single submitter | clinical testing |